Cedazuridine / Decitabine Dosage
Medically reviewed by Drugs.com. Last updated on Dec 5, 2024.
Applies to the following strengths: 100 mg-35 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Myelodysplastic Syndrome
1 tablet (containing 100 mg cedazuridine and 35 mg decitabine) orally once daily on Days 1 through 5 of each 28-day cycle for a minimum of 4 cycles until disease progression or unacceptable toxicity; a complete or partial response may take longer than 4 cycles
Comments:
- Consider administering antiemetics prior to each dose to minimize nausea and vomiting.
Use: For myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups
Renal Dose Adjustments
Mild (CrCl 60 to less than 90 mL/min) or moderate (CrCl 30 to less than 60 mL/min): No adjustment recommended.
Severe (15 to less than 30 mL/min) or end-stage (CrCl less than 15 mL/min) renal impairment: Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Obtain complete blood cell counts prior to initiating therapy and before each cycle; delay the next cycle if absolute neutrophil count (ANC) is less than 1000/microliter and platelets are less than 50,000/microliter in the absence of active disease. Monitor complete blood cell counts until ANC is 1000/microliter or greater and platelets are 50,000/microliter or greater.
Precautions
CONTRAINDICATIONS:
- None
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Do not substitute this drug combination for an IV decitabine product within a cycle.
- Take this drug at the same time each day.
- Swallow tablets whole; do not cut, crush, or chew tablets.
- Take this drug on an empty stomach 2 hours before or 2 hours after food.
- If a dose is missed within 12 hours of the time it is usually taken, take the missed dose as soon as possible and then to resume the normal daily dosing schedule.
- Extend the dosing period by one day for every missed dose to complete 5 daily doses for each cycle.
- Do not take an additional dose if vomiting occurs but continue with the next schedule dose.
Monitoring:
- Absolute neutrophil count (ANC)
- Complete blood cell count
- Platelets
More about cedazuridine / decitabine
- Check interactions
- Compare alternatives
- Reviews (3)
- Side effects
- During pregnancy
- Drug class: antineoplastic combinations
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.